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2Abstract
Recent fermentation studies have identified actinomycetes of the marine-dwelling genus
Salinispora as prolific natural product producers. To further evaluate their biosynthetic potential, we
analyzed all identifiable secondary natural product gene clusters from the recently sequenced
5,184,724 bp S. tropica CNB-440 circular genome. Our analysis shows that biosynthetic potential
meets or exceeds that shown by previous Streptomyces genome sequences as well as other natural
product-producing actinomycetes. The S. tropica genome features nine polyketide synthase
systems of every known formally classified family, non-ribosomal peptide synthetases and several
hybrid clusters. While a few clusters appear to encode molecules previously identified in
Streptomyces species, the majority of the 15 biosynthetic loci are novel. Specific chemical
information about putative and observed natural product molecules is presented and discussed. In
addition, our bioinformatic analysis was critical for the structure elucidation of the novel polyene
macrolactam salinilactam A. This study demonstrates the potential for genomic analysis to
complement and strengthen traditional natural product isolation studies and firmly establishes the
genus Salinispora as a rich source of novel drug-like molecules.
3Introduction
Actinomycetes are an exceptionally prolific source of secondary metabolites accounting for
more than half of all microbial antibiotics discovered to date (1). Remarkably, the vast majority of
these compounds are derived from the single actinomycete genus Streptomyces, raising the
intriguing possibility that additional, chemically prolific taxa await discovery. Further incentive to
explore actinomycetes as a source of novel secondary metabolites comes from the genome
sequences of S. coelicolor (2) and S. avermitilis (3), both of which revealed many unanticipated
biosynthetic gene clusters thus demonstrating that even well-studied taxa have the potential to yield
new metabolites. Such genomic-based information has been used not only to predict the chemical
structures of previously unobserved metabolites but also to develop fermentation methods that
enhance their production (4-7). Bioinformatics-based approaches to natural product discovery have
also been used successfully at the industrial level, where genome scanning has led to the discovery
of significant new chemical entities (8, 9). These methods have great potential to eliminate the
redundant isolation of previously described compounds while allowing detailed fermentation
studies or molecular cloning experiments to be focused on strains that possess a high probability of
producing new chemical structures.
Genomics has already been particularly useful to microbial natural products studies because
actinomycete secondary metabolites such as polyketides, nonribosomal peptides, and hybrids
thereof are often biosynthesized by large, multifunctional synthases that in an assembly line process
sequentially assemble small carboxylic acid and amino acid building blocks into their products
(10). The biosynthetic genes responsible for the production of these metabolites are almost
invariably tightly packaged into operon-like clusters that include regulatory elements and resistance
mechanisms (2). In the case of modular polyketide synthase (PKS) and nonribosomal peptide
synthetase (NRPS) systems, the repetitive domain structures associated with these megasynthases
generally follow a co-linearity rule (11) which, when combined with bioinformatics and biosynthetic
4precedence, can be used to predict the chemical structures of new polyketide and peptide-based
metabolites.
Marine-derived actinomycetes have become a focus in the search for novel secondary
metabolites (12). Among the strains cultured from marine samples is the genus Salinispora, which
was recently described as the first seawater-requiring marine actinomycete (13). This genus is
widely distributed in tropical and subtropical ocean sediments and is currently comprised of the two
formally described species, S. tropica and S. arenicola, and a third species for which the name S.
pacifica has been proposed (14). These actinomycetes are proving to be an exceptionally rich
source of structurally diverse secondary metabolites, which are produced in species-specific
patterns (15). In the case of S. tropica, the compounds observed to date from this bacterium include
the potent proteasome inhibitor salinosporamide A (16), which is currently in phase I human
clinical trials for the treatment of cancer, the unprecedented halogenated macrolides sporolides A
and B (17), lymphostin, which was observed by scientists at Nereus Pharmaceuticals during
salinosporamide A fermentation development (R. Lam, personal communication) and was first
reported from a Streptomyces species (18) and, salinilactam, the structure of which was solved as
part of the present study.
Here we report all identified secondary metabobolic biosynthetic gene clusters deriving
from the complete genome sequence of the marine actinomycete S. tropica strain CNB-440. This
strain is now found to hold the most diverse assemblage of polyketide biosynthetic mechanisms
observed in a single organism, as well as the largest percentage of a genome devoted to natural
product biosynthesis to date. Bioinformatic analysis was used to facilitate the structure elucidation
of the novel polyene macrolactam salinilactam A. Sequence analyses further revealed that many of
these clusters are likely to have been introduced into this genome as a result of recent horizontal
gene transfer, which has important implications to origin of this organism’s secondary metabolome.
5Results and Discussion
General features of the genome and associated secondary metabolome. The complete
genome sequence of S. tropica strain CNB-440 revealed a single circular chromosome comprising
5,184,724 bp, with no plasmids, and an average G+C content of 69.5% (Fig. 1).  S. tropica has
approximately 4,500 predicted protein-coding sequences and is similar in size when compared to
other actinomycetes that harbor circular chromosomes [Mycobacterium tuberculosis (19), Frankia
sp. CcI3 (GenBank accession CP000249), and Nocardia farcinica (20)], yet is substantially
smaller than those with linear chromosomes [S. coelicolor (2) and Rhodococcus sp. RHA1 (21)]
(Table 1).
Biosynthetic gene clusters were initially identified from a draft genome sequence provided
by the Joint Genome Institute (publicly released September 1, 2006), and checked against a single
contiguous sequence provided in advance of public release. Each putative open reading frame
(ORF) was compared against a representative library of all known PKS and NRPS domains, as
well as known biosynthetic accessory-type genes (including, but not limited to, cytochrome P450s,
terpene cyclases, prenyl transferases, methyl transferases, NAD(P)H-dependent oxidoreductases,
and CoA/AMP ligases).
This analysis revealed 15 secondary metabolic biosynthesis gene clusters that we predict to
be involved in siderophore, melanin, polyketide, non-ribosomal peptide, and aminocyclitol
production (Table 1). The combined length of these gene clusters is estimated at 492 kb,
establishing that, amongst sequenced bacteria to date, S. tropica devotes the largest percentage of its
genome (~9.5%) to natural product assembly (Table 1).  These analyses also confirm that the
biosynthetic potential of this strain is considerably greater than that observed by fermentation, as
was previously reported in analyses of the S. coelicolor and S. avermitilis genome sequences (2, 3).
Two thirds of the clusters are concentrated in a single quadrant of the chromosome nearly
antipodal to the replication-controlling dnaA gene (Fig. 1). This section of the genome also harbors
6a significant proportion of the approximate 128 chromosomal mobile genetic elements such as
transposases, integrases, resolvases and phage-related ORFs. Many reside in close proximity to
secondary metabolic clusters (pks1, sal, spo, amc, sid3, slm) while several clusters have strong
similarity in ORF and domain organization to existing gene clusters (sid2, sid3, pks3), strongly
suggesting that many of these clusters may have originated from donor genomes via horizontal
gene transfer.
Biosynthetic capabilities of S. tropica. The majority of identified S. tropica secondary
metabolite gene clusters utilize carrier protein-based biosynthetic logic in the assembly of their
products. Hence, biosynthetic precursors and intermediates are expected to be largely protein-
bound during the assembly process and are not likely to crosstalk with other primary or secondary
metabolic pathways. Salinispora tropica harbors at least five (Stro0922, Stro2003, Stro3049,
Stro3460, Stro3545) 4’-phosphopantetheinyl transferase (PPTase) (22) encoding genes whose
products transfer the 4’-phosphopantetheine moiety from coenzyme A to the ~35 conserved serine
residues in fatty acid synthase-, PKS-, and NRPS-associated carrier proteins. Three are found in
identified carrier protein-containing biosynthetic clusters (Stro0922 with sid3, Stro2003 with pks3,
and Stro3545 with nrps2) and thus may be specific to their pathways.
A striking feature of the S. tropica genome is its remarkable diversity of polyketide
biosynthetic pathways, which is greater in variety than in other sequenced bacterial genomes (Table
1). Pathways include those for modular type I PKSs (slm), iterative enediyne type I PKSs (spo and
pks1), hybrid type I PKS–NRPSs (sal, sid2, sid3, and lym), heterodimeric type II PKSs (pks2 and
pks3), and a homodimeric type III PKS (pks4) (Fig. 1). Interestingly, none of the type I PKS-
associated modules, of which there are 15, contain a full set of reductive domains required to
completely reduce the transient β-carbonyl group to a saturated methylene carbon during the
polyketide elongation process. Hence, S. tropica PKS-derived products are expected to be highly
oxidized, as is the case for the characterized metabolites salinosporamide A (sal), sporolide A (spo),
lymphostin (lym), and salinilactam A (slm) (Fig. 2).
7A primary motivation for the sequencing of the CNB-440 strain of S. tropica was that it is a
producer of the potent anticancer agent salinosporamide A (16). Its biosynthetic gene cluster (sal)
encodes a 29-ORF, 41-kb unprecedented hybrid PKS–NRPS pathway (Fig. 2E) involving new
mechanisms in chlorination and β-lactone synthesis as well as 20S proteasome resistance (23). In
addition to the sal cluster, S. tropica harbors two additional hybrid PKS–NRPS pathways. The lym
cluster is proposed to synthesize the lymphocyte kinase inhibitor lymphostin, which was first
isolated from Streptomyces sp. KY11783 (18). We propose that the uniquely organized two-
module synthase LymA catalyzes a single polyketide extension followed by reductive offloading
and N-acetylation of a non-proteinogenic tricyclic planar amino acid derived from tryptophan, with
subsequent O-methylation catalyzed by an adjacent SAM-dependent methyl transferase LymB
(Fig. 2F). A set of four genes with homology to a domain of unknown function (DUF611) may
play a role in the synthesis of the tryptophan-derived primer unit. The sid2 cluster bears strong
domain organization (though lacks direct sequence similarity) to the yersiniabactin cluster (ybt)
from Yersinia pestis (24) and other organisms (Fig. 2B). Although no siderophore molecules have
yet been isolated from Salinispora species, the notable similarity in domain structure very strongly
suggests that the resulting molecule will have the yersiniabactin polyketide/non-ribosomal peptide
core with possible alterations in sites of methylation and/or oxidation.
Two independent, novel enediyne PKS biosynthetic gene clusters (spo and pks1) are found
in the S. tropica genome. Enediyne natural products, such as the potent DNA cleaving agents
calicheamicin, dynemicin, C-1027, and neocarzinostatin are polyketide secondary metabolites
produced by members of the order Actinomycetales, many of which (like the genus Salinispora)
belong to the family Micromonosporaceae (25). The enediyne polyketide structural motif falls into
two classes that possess either 9- or 10-membered rings, and their associated PKSs are
phylogenetically distinct. Phylogenetic analysis of the S. tropica enediyne PKSs associated with the
spo and pks1 clusters revealed that they are putatively involved in the biosynthesis of distinct 9- and
10-membered enediyne polyketides, respectively (Fig. 3). While no enediyne natural products have
yet been directly characterized from S. tropica, sporolides A and B (17) are putatively derived from
8a 9-membered enediyne PKS product that is uniquely halogenated with chloride during the
aromatization of the enediyne unit to yield the tricyclic hydrocarbon nucleus (26). The ~71-kb spo
cluster harbors as many as 53 ORFs, which include other conserved enediyne PKS-associated
genes, as well as those encoding the postulated biosynthesis and coupling of the sporolide
cyclohexenone unit deriving from the amino acid tyrosine. The 10-membered enediyne PKS in
gene cluster pks1 also bears the canonical enediyne PKS domain architecture, and further analysis
of its 30-kb gene cluster did not reveal accessory genes involved in deoxyhexose biosynthesis and
attachment, nor additional polyketide pathways typically associated with 10-membered enediyne
polyketide biosynthesis (i.e., calicheamicin and dynemicin), suggesting that this orphan pathway
codes for the biosynthesis of a novel natural product.
In addition to the abundance of diverse PKS pathways, S. tropica harbors four NRPS
operons (nrps1, nrps2, sid3, and sid4) (Fig. 1). While the products of the dimodular nrps1 and
novel tetramodular nrps2 gene clusters are unknown and could not be accurately predicted on the
basis of bioinformatics alone (27, 28), sid3 and sid4 are homologous to gene sets encoding known
siderophore pathway biosynthetic enzymes. When combined with the highly homologous S.
coelicolor NRPS-independent siderophore desferrioxamine (29) cluster sid1 (Fig. 2A) and the ybt
homologous PKS–NRPS hybrid cluster sid2 (Fig. 2B), a total of four identifiable siderophore-like
clusters reside in S. tropica. The three assembly line siderophore synthetases encoded by gene sets
sid2–4 each have related priming mechanisms involving homologous ATP-dependent aryl-CoA
ligases, which typically incorporate aromatic residues such as salicylate or 2,3-dihydroxybenzoate
into their NRP siderophore products such as yersiniabactin, enterobactin, and pyochelin (30). The
sid4 gene cluster has strongest homology with a biosynthetic cluster for an as-yet unisolated
siderophore (‘coelibactin’) from S. coelicolor (Fig. 2D) (2). The S. tropica sequence, however,
differs from that in S. coelicolor in that it is flanked by an additional transport system typical of
siderophore export and iron-bound uptake. The smaller sid3 cluster is adjacent to the sid4 cluster
and encodes a highly unusual type II PKS and a single NRPS module that we propose to extend
and cyclize an aromatic acid with cysteine, tentatively producing a siderophore-like intermediate
9(Fig. 2C). It is unclear if sid3 is fully functional or is instead biosynthetically linked with sid4.
While the latter three gene clusters are traditionally found in γ-proteobacteria, these S. tropica gene
clusters bear %G+C values similar to the S. tropica total genome percentage, and therefore do not
suggest a very recent assimilation, despite similarities to existing clusters.
Genome-guided natural product discovery of salinilactam A. The slm cluster is the
largest S. tropica biosynthetic cluster and consists of six genes encoding a ten-module PKS with
49 domains. Due to the highly repetitive nature of the DNA sequence associated with the slm loci
and an extremely high level of sequence identity (>99% in many regions), assembly of the cluster
and, as a consequence, closure of the genome was problematic. Initial inspection of the partial slm
gene cluster from an early draft genome sequence suggested that it coded for a novel lysine-primed
polyene macrolactam polyketide devoid of sugar or other appendages often associated with
polyketide natural products. A fermentation broth of S. tropica CNB-440 was inspected for new
compounds with characteristic UV chromophores associated with polyene units, which led to the
isolation of a series of new polyene macrolactams exemplified by salinilactam A (Fig. 2G). NMR
and MS characterization of salinilactam A quickly revealed a novel polyene macrolactam
framework, which was only consistent with the slm cluster. Structural features included two isolated
polyene fragments, a 1,2,3,5-tetrahydroxy alkane moiety, three methyl groups, and an amide
functionality. However, completion of the structure was initially hindered due to the instability of
the compound and the presence of eight conjugated olefins with similar NMR properties.
Inspection of the structure fragments, together with the molecular formula C2 8H3 9NO5
revealed by high-resolution mass spectrometry, suggested that salinilactam A was derived from a
PKS with at least ten extension modules. This information was useful to help resolve and properly
assemble the repetitive DNA sequences associated with slm into two operons (slmABCD and
slmNO) separated by nine accessory genes presumed to be involved in starter unit biosynthesis and
macrolactam hydroxylation (Fig. 2G). On the basis of the co-linearity rule of modular polyketide
biosynthesis, the relationship of slm to the terminal region of the vicenistatin PKS (31), and partial
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NMR-based structural fragments, we were able to accurately predict the gross chemical structure of
salinilactam A. The natural product would thus be produced by chain extension of the novel lysine-
derived PKS starter unit 5-aminohex-2-enoate with eight malonate and two methylmalonate units
followed by macrolactamization and cytochome P450 hydroxylation at C-8.
The salinilactam A structure was verified by comprehensive NMR analyses on the purified
natural product to confirm the bioinformatics-based structure assignment. Although the relative and
absolute stereochemistry of salinilactam A was not determined spectroscopically, the
stereochemistry of the C-7, C-9, and C-11 hydroxyl groups was predicted to be R, S, and R,
respectively, based upon strong homology of all slm ketoreductase (KR) domains to other “A-
type” KRs (32). The intimate interplay between microbial genomics, biosynthetic logic and natural
product chemistry was critical not only in the structure elucidation of this new chemical entity, but
also in the final closure of the genome sequence.
Conclusions
There is an ongoing resurgence in natural product drug discovery research (33).  This
renewed interest is driven by the inherent structural diversity and biological activity associated with
secondary metabolites, the low productivity of alternative drug discovery strategies, and the
application of improved analytical methods that make it possible to solve structures using small
quantities of material.  A relatively new concept that can be added to this list is the molecular
genetics of natural product biosynthesis (34).  Advances in this field, in combination with increased
access to DNA sequencing, are providing a wealth of information about how natural products are
assembled, mechanisms by which natural product gene clusters can be manipulated to yield new
product diversity, and the genetic potential of individual organisms.  Concerning the later, complete
genome sequencing provides unparalleled access to the genes involved in secondary metabolism,
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how they are assembled, and in some cases, what products they may yield.  Armed with these data,
it becomes possible to compare the compounds observed using traditional fermentation procedures
with those that are predicted from gene sequences, design fermentation methods that may activate or
enhance the production of predicted products, and assess the evolutionary history of individual gene
clusters.  The genus Salinispora has become a model organism to address questions about species-
specific patterns of natural product production (15) and, as described in the present study, the
application of whole genome sequencing to the process of natural product discovery and structure
elucidation.
Genome sequencing of S. tropica has revealed an abundance of novel biosynthetic gene
clusters, the majority of which were unexpected based on previous fermentation analyses of this and
closely related species and strains. With this information now available, there is a clear need for
further genome-guided fermentation studies as our analysis clearly confirms the value of the
Salinispora genus as a source of novel drug-like molecules. In the absence of other
Micromonsporacea genome sequences, it is unclear if this natural product diversity is general to
this family or if the diversity in the genus Salinispora derives from environmental novelty.
Sequencing of a related species, Salinispora arenicola CNS-205, already underway, should shed
further light on the metabolic capabilities of this newly described marine actinomycete genus.
Outside of the exploratory aspects of this project, our bioinformatic analysis was of broad
practical utility in conjunction with natural product isolation. The isolation of a large polyene
molecule led to identification and resolution of a large, repetitive PKS sequence, the analysis of
which spurred further refinement and identification of salinilactam A as a novel polyene. With the
genome information in hand we expect that it will facilitate similar studies in the future, and this
result demonstrates the benefits that can result from greater interplay between information
technology and natural product structure elucidation. We recently developed a genetics system in S.
tropica for rapid gene knockouts via PCR targeting that will further facilitate the genome mining of
this metabolically rich bacterium (23).
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Currently, the implications for secondary metabolism due to the circular nature of the S.
tropica chromosome are unclear. A mechanism for the biogenesis of novel secondary metabolic
clusters in linear chromosomes was recently reported (35), and makes clear that the instability
found at of the terminal ends of Streptomyces linear chromosomes has been utilized to provide
rapid evolutionary adaptability to the organism. By contrast, no particular region of the circular S.
tropica chromosome seems unstable to the same degree observed in the chromosomal ends of
Streptomyces as pseudogenes are largely absent and secondary metabolic clusters and transposable
elements are more dispersed throughout the chromosome. This may indicate that Salinispora
species will have more frequently acquired their secondary metabolic systems horizontally from
other species rather than evolving most themselves. It will be appealing to put this hypothesis to the
test when the S. arenicola CNS-205 genome is completed and directly compared to S. tropica
CNB-440.
Materials and Methods
Genome sequencing, annotation and analysis. Draft sequencing and automated annotation was
provided by the Department of Energy, Joint Genome Institute (JGI) under the Community
Sequencing Program and has been deposited with GenBank (AATJ00000000). Automated gene
prediction and functional annotation was performed by the Genome Analysis Pipeline (36).
Automated prediction of protein-coding genes was based on the output of CRITICA (37)
complemented with the output of Glimmer (38). Initial functional annotation was performed using
similarity searches against TIGRFAM (39), PRIAM (40), Pfam (41), SMART (42), COGs (43),
SwissProt/TrEMBL (44) and KEGG (45) databases using a set of rules for assigning a specific
product description depending on the combination of the search results; product descriptions were
further manually refined. Annotated genome sequences are available at the Microbial Portals at
http://genome.ornl.gov/microbial/ and through the Integrated Microbial Genomes (IMG) system
(46) at http://img.jgi.doe.gov/.
13
To more specifically identify and categorize natural product biosynthetic gene clusters, a
custom Perl script was written to sequentially search each translated protein sequence via BLASTP
alignment against a hand-constructed and expandable library of model natural product domains and
genes. Hits were grouped by physical proximity within the chromosome, and putative clusters were
further examined using software available at the NCBI website and visualized with Vector NTI
(Invitrogen). Transposons and other mobile genetic element ORFs were identified in a similar
manner. Annotations of all gene clusters discussed were deposited with GenBank (for accession
numbers, see Table 2).
Salinilactam A isolation and characterization. Strain CNB-440/ΔsalD was cultured in
9 x 1L Fernbach flasks containing A1bFe+C medium (10 g starch, 4 g yeast extract, 2 g peptone, 1
g CaCO3, 5 mL Fe2(SO4)3·4H2O at 8 g/L, 5 mL KBr at 20 g/L, 1 liter seawater) at 27°C while
shaking at 230 rpm. XAD-7 resin (20 g) was added to each flask after 24 hr, and the fermentation
was continued for another six days. The resin was filtered, washed with water, and then extracted
with acetone to afford 1.1 g of crude extract, which was fractionated by reversed-phase C18 vacuum
liquid chromatography eluting with increasing amounts of methanol in water. The third fraction that
eluted with 60% methanol (105 mg) was purified by RP-HPLC [Prep Nova-Pak HR C18, 6 µm,
60Å, 300 mm x 40 mm, flow rate 10 mL/min, detection at 210 nm, 25% for 10 min then a linear
gradient up to 40% CH3CN over 15 min and linear gradient to 100% over another 25 min] to afford
salinilactam A (tR = 25 min, 1.5 mg): light yellow solid; [α]D –28.8 (c 0.06, MeOH); UV (MeOH)
λmax (log ε) 250 (4.01), 305 (4.51), 335 (4.26), 355 (4.18) nm; IR (NaCl) λmax 3464, 2930, 1739,
1547, 1414, 1279, 1135, 1074, 998, and 743 cm-1; 1H NMR (500 MHz, CD3OD) δ 7.02 (1H, dd, J
= 15.6, 10.7 Hz, H-3), 6.76 (1H, d, J = 14.6 Hz, H-17), 6.51 (1H, dd, J = 15.0, 10.2 Hz, H-20), 6.49
(1H, dd, J = 14.8, 10.3 Hz, H-14), 6.30 (1H, dd, J = 15.0, 10.2 Hz, H-16), 6.29 (1H, dd, J = 14.8,
10.2 Hz, H-15), 6.27 (1H, dd, J = 14.9, 10.5 Hz, H-13), 6.25 (1H, dd, J = 15.1, 10.7 Hz, H-4), 6.10
(1H, dd, J = 14.6, 10.5 Hz, H-21), 6.05 (1H, dd, J = 15.0, 10.0 Hz, H-22), 6.02 (1H, dd, J = 15.1,
10.1 Hz, H-5), 5.95 (1H, d, J = 15.1 Hz, H-19), 5.87 (1H, d, J = 15.2 Hz, H-2), 5.77 (1H, dd, J =
14
14.8, 10.5 Hz, H-12), 5.67 (1H, ddd, J = 15.0, 10.1, 7.0 Hz, H-23), 4.36 (1H, q, J = 11.2, 4.1 Hz, H-
11), 3.97 (1H, dt, J = 11.2, 6.8, 4.1 Hz, H-9), 3.86 (1H, m, H-25),  3.60 (1H, dd, J = 7.7, 4.1 Hz, H-
8), 3.50 (1H, dd, J = 7.7, 5.0 Hz, H-7), 2.59 (1H, m, H-6), 2.33 (1H, m, H-24a), 2.19 (1H, ddd, J =
14.1, 7.0, 6.5 Hz, H-24b), 1.98 (1H, m, H-10a), 1.84 (3H, s, H3-28), 1.78 (1H, dd, J = 14.8, 6.8 Hz,
H-10b), 1.27 (3H, d, J = 7.1 Hz, H3-26), 1.08 (3H, d, J = 7.2 Hz, H3-27); 1 3C NMR (125 MHz,
CD3OD) δ 168.2 (C-1), 142.1 (C-5), 139.4 (C-3), 138.9 (C-20), 136.9 (C-12), 134.4 (C-22), 133.1
(C-18), 131.2 (C-15), 130.5 (C-19), 130.3 (C-23), 129.6 (C-17), 129.4 (C-21), 128.9 (C-16), 128.8
(C-14), 128.7 (C-4), 128.6 (C-13), 123.1 (C-3), 75.6 (C-7), 75.2 (C-8), 71.3 (C-11), 69.3 (C-9),
46.7 (C-25), 39.5 (C-10), 39.4 (C-24), 38.7 (C-6), 19.7 (C-25), 19.4 (C-28), 13.8 (C-27); ESIMS
m/z 452 (M – H2O + H), 470 (M + H), 492 (M + Na), 961 (2M + Na); HRESITOFMS m/z
492.2720 [calcd for C2 8H3 9NO5Na+, 492.2726].
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Captions
Fig. 1.   Circular chromosome of Salinispora tropica CNB-440, oriented to dnaA gene. Outer ring,
locations of secondary metabolic gene clusters. Inner ring, locations of identified mobile genetic
elements.
Fig. 2.   Selected genes from S. tropica modular biosynthetic enzyme systems and their associated
natural products.  (A-D) putative siderophore clusters: (A) sid1 cluster in comparison to the
desferrioxamine cluster from Streptomyces coelicolor A3(2). (B) sid2 cluster in comparison to the
yersiniabactin cluster from Yersinia pestis. (C) sid3 cluster with putative product intermediate. (D)
sid4 cluster in comparison to proposed S. coelicolor ‘coelibactin’ cluster (unconfirmed structure).
(E-G) Novel modular enzyme systems: (E) salAB from proposed salinosporamide cluster. (F)
lymAB from proposed lymphostin cluster. (G) modular PKS system from salinilactam cluster
(stereochemistry proposed, green portion is derived from the proposed lysine-based starter unit).
Domain notation: A, adenylation (amino acid substrate noted); C, condensation; Ccyc, condensation
with cyclization; PCP, peptidyl carrier protein; KS, β-ketoacyl synthase; AT, acyl-CoA/ACP
transacylase (activates malonyl-CoA unless otherwise noted); mAT, methylmalonyl-CoA/ACP
transacylase; DH, dehydratase; ACP, acyl carrier protein; KR, ketoreductase; TE, thioesterase; OR,
oxidoreductase; MT, SAM-dependent methyltransferase; NAT, N-acetyl transferase; unk,
unknown.
Fig. 3.   (A) Representative enediyne structures (B) phylogenetic tree of representative enediyne
PKSs. GenBank accessions: MadE, AAQ17110; NcsE, AAM78012; SgcE, AAL06699; CalE8,
AAM94794; EspE, AAP92148; DynE, AAN79725. (C) Proposed biosynthesis of sporolide A.
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Table 1 - S. tropica CNB-440 genome data in comparison to other actinomycete natural product
producers
Organism
S. tropica
CNB-440
S. coelicolor
A3(2)
M. tuberculosis
H5N1
Frankia
sp. CcI3
N. farcinica
IFM 10152
Size 5.18 Mb 8.72 Mb 4.41 Mb 5.43 Mb 6.01 Mb
Chromosome organization circular linear circular circular circular
%G+C content 69.5% 72% 67% 70% 70%
% of genome dedicated to
secondary metabolism ~9.5% ~8%
Not
determined
Not
determined
Not
determined
Major NP clusters
Modular Type I PKS 1 2 7 4 4
Enediyne PKS 2 - - - -
Type II PKS 2 2 1 2 1
Type III PKS 1 3 3* - 1
Mixed PKS/NRPS 4 - - 1 1
NRPS 3 3 2 3 7
non-NRPS siderophore 1 1 - 1 -
* Two type III PKS enzymes are associated with the modular type I PKSs pks7, pks8, pks9, pks17.
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Table 2 - S. tropica CNB-440 biosynthetic gene clusters
Cluster
designation
Actual (*) or
predicted product
Type %G
+C
Size GenBank
Accession
pks1 10-membered enediyne Enediyne PKS 67 30 kb xx
pks2 Glycosylated decaketide Type II PKS 69 35 kb xx
pks3 Spore pigment Type II PKS 71 23 kb xx
spo Sporolide* Enediyne PKS 68 71 kb xx
slm Salinilactam* Type I PKS 70 80 kb xx
pks4 Aromatic polyketide Type III PKS 73 4 kb xx
nrps1 Unknown dipeptide NRPS 68 31 kb xx
nrps2 Reductively offloaded
tetrapeptide
NRPS 70 33 kb xx
sal Salinosporamide* PKS-NRPS 67 41 kb xx
lym Lymphostin* PKS-NRPS 71 33 kb xx
sid1 Desferrioxamine-like
siderophore
NRPS-
independent
72 38 kb xx
sid2 Yersiniabactin-like
siderophore
PKS-NRPS 71 28 kb xx
sid3 Unknown siderophore PKS-NRPS 72 30 kb xx
20
sid4 ‘Coelichelin’-like
siderophore
NRPS 70 10 kb xx
amc Unknown aminocyclitol Aminocyclitol 70 8 kb xx
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